Subcutaneous versus intravenous pembrolizumab, in combination with chemotherapy, for treatment of metastatic non-small-cell lung cancer: the phase III 3475A-D77 trial

作者：E. Felip, C.I. Rojas, M. Schenker, D.M. Kowalski, Ignacio Casarini, Tibor Csőszi, Mehmet Alı Nahıt Şendur, José Diogo Martins, Antonio Calles, C.-C. Wang, Min Wang, Rixci Augusto Lenin Ramirez Fallas, Hiroshige Yoshioka, Suresh Nair, Xiaoyu Song, Xiaoyan Deng, Mallika Lala, R. Eiras, T. Takahashi · 发表于：Annals of Oncology · 年份：2025 · DOI：10.1016/j.annonc.2025.03.012 · 被引用次数：33 · 研究领域：Cancer Immunotherapy and Biomarkers、Peptidase Inhibition and Analysis、Lung Cancer Diagnosis and Treatment